{"organizations": [], "uuid": "41677c978bd5dd11dc9fb30c12e5ab2be742524d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180427.html", "section_title": "Archive News &amp; Video for Friday, 27 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-yichang-hec-changjiang-pharmaceuti/brief-yichang-hec-changjiang-pharmaceutical-announces-china-fda-approval-for-esomeprazole-sodium-for-injection-idUSFWN1S41I1", "country": "US", "domain_rank": 408, "title": "BRIEF-Yichang Hec Changjiang Pharmaceutical Announces China FDA Approval For Esomeprazole Sodium For Injection", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-27T23:17:00.000+03:00", "replies_count": 0, "uuid": "41677c978bd5dd11dc9fb30c12e5ab2be742524d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-yichang-hec-changjiang-pharmaceuti/brief-yichang-hec-changjiang-pharmaceutical-announces-china-fda-approval-for-esomeprazole-sodium-for-injection-idUSFWN1S41I1", "ord_in_thread": 0, "title": "BRIEF-Yichang Hec Changjiang Pharmaceutical Announces China FDA Approval For Esomeprazole Sodium For Injection", "locations": [], "entities": {"persons": [], "locations": [{"name": "china", "sentiment": "none"}], "organizations": [{"name": "hec changjiang pharmaceutical announces china fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "yichang hec changjiang pharmaceutical co ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd:\n* ESOMEPRAZOLE SODIUM FOR INJECTION 40MG & 20MG APPROVED BY CHINA FDA FOR LAUNCHING INTO MARKET Source text : [ bit.ly/2r5DdWX ] Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://bit.ly/2r5DdWX", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-27T23:17:00.000+03:00", "crawled": "2018-04-28T13:09:05.005+03:00", "highlightTitle": ""}